No major trial has directly compared dronedarone (Multaq, Sanofi-Aventis) against amiodarone. If dronedarone is approved for atrial fibrillation, would you recommend its use as a first-line agent, before attempting amiodarone?
See: FDA advisory panel recommends dronedarone approval for atrial fib